Study of the Diagnostic Value of Hybrid PET/MR and PET/CT in Neuroendocrine Diseases and Tumor Induced Osteomalacia
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
A observational or N/A phase clinical study on Neuroendocrine Tumors and Osteomalacia, this trial is ongoing. The trial is conducted by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology and has accumulated 12 data snapshots since 2019. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Aug 2025 — Sep 2025 [monthly]
Unknown
-
Mar 2025 — Aug 2025 [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Mar 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
▶ Show 7 earlier versions
-
Mar 2023 — Jul 2024 [monthly]
Recruiting
-
May 2022 — Mar 2023 [monthly]
Recruiting
-
Dec 2021 — May 2022 [monthly]
Recruiting
-
Mar 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Recruiting
-
Oct 2020 — Jan 2021 [monthly]
Recruiting
-
Sep 2019 — Oct 2020 [monthly]
Recruiting
First recorded
May 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
For direct contact, visit the study record on ClinicalTrials.gov .